Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 12,801	$ 1,034
Adjustments to reconcile net income to cash provided (used) by operating activities:
Depreciation and amortization	556	497
Allowance for doubtful accounts	29	26
Amortization of deferred finance cost	41	6
Value of share-based payment arrangements	134	69
Deferred tax (benefit) utilization	(1,036)	583
Changes in assets and liabilities:
Trade accounts receivable	468	(712)
Inventories	(22,433)	477
Prepaid expenses and other current assets	(65)	(235)
Other assets	(303)	(19)
Accounts payable and accrued expenses	542	(1,113)
Cash provided(used) by operating activities	(9,266)	613
Cash flows from investing activities:
Additions to patents	(19)	(43)
Additions to property, plant, and equipment	(1,248)	(903)
Investment in affiliates	(730)	0
Cash used by investing activities	(1,997)	(946)
Cash flows from financing activities:
Proceeds from issuance of common stock - net	122	3
Repurchase of warrants	0	(90)
Proceeds of short-term debt - net	10,527	1,470
Proceeds from long-term debt	4,387	0
Repayment of long-term debt	(3,740)	(1,018)
Cash provided by financing activities	11,296	365
Increase in cash and cash equivalents	33	32
Cash and cash equivalents at beginning of period	3,958	3,926
Cash and cash equivalents at end of period	3,991	3,958
Supplemental disclosure of cash flow information:
Cash paid during period for interest	652	862
Cash paid for income taxes	2,553	59
Non Cash Investing and Finance Securities
Investment in affiliates	408	0
Issuance of common stock in connection with asset purchase	$ 600	$ 0